BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 3 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 3 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 5 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 days ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 days ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 days ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 days ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 2 days ago Abbott reports positive results from study on its atrial fibrillation therapies 2 days ago Atmus Welcomes Heath Sharp to Board of Directors 3 days ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 3 days ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 4 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 5 days ago
ADVERTISEMENT
Market News

Johnson & Johnson (JNJ) Q1 2021 Earnings Call

Johnson & Johnson  (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021 Corporate Participants: Christopher DelOrefice — Vice President of Investor Relations Joseph J. Wolk — Executive Vice President and Chief Financial Officer Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer Alex Gorsky — Chairman, Board of Directors and Chief Executive Officer Joaquin Duato — Vice Chairman of the Executive Committee Analysts: […]

$JNJ April 21, 2021 1 min read

Johnson & Johnson  (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021

Corporate Participants:

Christopher DelOrefice — Vice President of Investor Relations

Joseph J. Wolk — Executive Vice President and Chief Financial Officer

Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer

Alex Gorsky — Chairman, Board of Directors and Chief Executive Officer

ADVERTISEMENT

Joaquin Duato — Vice Chairman of the Executive Committee

Analysts:

Chris Schott — J.P. Morgan — Analyst

Larry Biegelsen — Wells Fargo — Analyst

Joanne Wuensch — Citi — Analyst

Bob Hopkins — Bank of America Merrill Lynch — Analyst

ADVERTISEMENT

Joshua Jennings — Cowen and Company — Analyst

Louise Chen — Cantor Fitzgerald — Analyst

Danielle Antalffy — SVB Leerink — Analyst

Matt Miksic — Credit Suisse — Analyst

Terence Flynn — Goldman Sachs — Analyst

ADVERTISEMENT

_________

To read the full earnings call transcript, click here

ADVERTISEMENT